AdipoPharma

Strasbourg, France

AdipoPharma SAS is clinical stage biotech dedicated to treat insulin resistance by targeting the adipocyte

$10.6M raised

Nov 2024

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has AdipoPharma raised?

AdipoPharma has raised $10.6M in total funding. The most recent round was Series A. The last funding was announced in November 2024.

Who are AdipoPharma's investors?

AdipoPharma's investors include Good Growth Capital, Okeanos, Newton Biocapital, Sambrinvest, InvestSud.

Where is AdipoPharma headquartered?

AdipoPharma is headquartered in Strasbourg, France.

What does AdipoPharma do?

AdipoPharma SAS is clinical stage biotech dedicated to treat insulin resistance by targeting the adipocyte

What stage is AdipoPharma at?

AdipoPharma is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 11, 2024.

MLA

"AdipoPharma — Funding & Investors." VCBacked, November 11, 2024, https://www.vcbacked.co/company/adipopharma. Accessed July 2, 2026.

APA

VCBacked. (2024). AdipoPharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/adipopharma

Wikipedia (cite web)

{{cite web |title=AdipoPharma — Funding & Investors |url=https://www.vcbacked.co/company/adipopharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 11, 2024.